University Of Vermont
Clinical trials sponsored by University Of Vermont, explained in plain language.
-
New combo therapy aims to tame AML without harsh chemo
Disease control ENROLLING_BY_INVITATIONThis early-stage study tests whether adding the anti-inflammatory drug dexamethasone to a standard low-intensity treatment (venetoclax plus another chemo drug) is safe and tolerable for adults with newly diagnosed acute myeloid leukemia (AML) who cannot have intensive chemotherap…
Phase: PHASE1 • Sponsor: University of Vermont • Aim: Disease control
Last updated Jun 17, 2026 00:27 UTC
-
Needle injection of chemo into lung tumors shows promise in early trial
Disease control OngoingThis early-phase study tested a new method to deliver the chemotherapy drug cisplatin directly into lung tumors using a thin needle guided by ultrasound. The goal was to find the highest safe dose for people with stage IV lung cancer. Sixteen participants were enrolled to monitor…
Phase: PHASE1 • Sponsor: University of Vermont • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC
-
Study on future thinking and smoking pulled before starting
Knowledge-focused TerminatedThis study was designed to see if asking smokers to imagine positive future events would change how they value losses and how much they smoke. It planned to enroll adults who smoke at least 5 cigarettes daily. However, the study was withdrawn before any participants were enrolled…
Phase: NA • Sponsor: University of Vermont • Aim: Knowledge-focused
Last updated Jun 17, 2026 00:31 UTC
-
New program aims to stop blood clots in cancer patients
Knowledge-focused ENROLLING_BY_INVITATIONThis study tests a modified clinical program to help doctors better prevent blood clots (VTE) in cancer patients starting treatment. About 25 patients and their doctors will take part. The program includes education for doctors and a structured risk assessment to decide if blood-…
Phase: NA • Sponsor: University of Vermont • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:07 UTC